DCZ5418

• CAT Number: I040162
• CAS Number: 2883709-99-5
• Molecular Formula: C22H22N2O3
• Molecular Weight: 362.42
• Purity: ≥95%
• Synonyms: (3aR,4S,7R,7aS)-3a,7a-dimethyl-2-[4-(pyridin-4-ylmethyl)phenyl]-4,5,6,7-tetrahydro-4,7-epoxyisoindole-1,3-dione
• InChI: InChI=1S/C22H22N2O3/c1-21-17-7-8-18(27-17)22(21,2)20(26)24(19(21)25)16-5-3-14(4-6-16)13-15-9-11-23-12-10-15/h3-6,9-12,17-18H,7-8,13H2,1-2H3/t17-,18+,21+,22-
• InChIKey: DZGUDPKHBIPNCC-MTIDIVMFSA-N
• SMILES: CC12C3CCC(C1(C(=O)N(C2=O)C4=CC=C(C=C4)CC5=CC=NC=C5)C)O3

DCZ5418 (Cat No.: I040162) is an investigational small molecule with potential applications in cancer therapy. It is designed to target specific molecular pathways involved in tumor growth and survival, aiming to inhibit key proteins or enzymes that contribute to cancer progression. While details on its exact mechanism of action are still under investigation, DCZ5418 shows promise in preclinical studies for its ability to modulate critical cellular processes such as apoptosis, cell cycle regulation, and metastasis. Its therapeutic potential is being explored in various cancer types.

Reference

[1]. Sanfeng Dong, et al. Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo. Bioorg Med Chem Lett. 2023.
[Content Brief]